$ABCL Per @mattocko AbCellera is “a multi-decade-deep engine of antibody-centric innovation, one the of the strongest and earliest unions of applied Al in biotech and lab-in-the-loop automation.”
Remember that statement when watching the video below and consider Carl Hansen’s
The value I, and many others, see in $ABCL lies far beyond the value of ABCL635 alone:
“A critic could look at our ABCL635 Phase 2 asset and our two undisclosed preclinical assets (ABCL386 and ABCL688) and make the claim that for $1B of invested capital, they would have
My interest in Chainlink pretty much comes down to this:
Tokenization of RWA is coming. I believe it’s going to be big. CEO of Blackrock Larry Fink says “We believe the next step going forward will be the tokenization of financial assets and that means every stock, every
$ABCL This thought keeps crossing my mind:
ABCL635 targets the NK3R GPCR to treat hot flashes in women. As it stands, the only available non-hormonal treatments are small molecules.
Targeting GPCRs with antibodies is very difficult. AbCellera is showing they can do it.
Then
Pulled the trigger and rotated those “trade” $ABCL shares I picked up over the last couple of months that were originally supposed to go to $PLTR and allocated them to a ~1% $LINK position as I learn more.
Now just riding with my core ABCL position, which will remain untouched
I think Chainlink is interesting.
Orchestration layer will command the value with LLMs. Will it be the same with blockchain?
IDGAF about crypto currency as an investment. But the infrastructure layer is interesting to me. My surface level understand is that Chainlink is the
$ABCL I love seeing AbCellera meet with members of the government like this.
and remember, Carl has been pounding the table for the government to support commercial innovation:
“What’s needed now is vision backed by bold action. Canada should establish a national Health